Skip to main content
. 2015 Aug 3;2(7):635–645. doi: 10.18632/oncoscience.180

Figure 1. Characterization of Cav-1 and PTRF expression in prostate cancer cell lines.

Figure 1

Cell lysates from prostate cancer cells were separated by SDS-PAGE and analysed by immunobloting with anti-caveolin-1 or anti-PTRF antibody as indicated. (A) LNCaP cells stably expressing GFP or Cav-1-GFP. (B) PC3 pooled cells stably transfected with non-targeting, control shRNA (sh-Cont) or with Cav-1 shRNA (sh-Cav-1). (C) DU145 cell clones stably transfected with scrambled shRNA (S1 and S2 clones) or with Cav-1 shRNA (C1 and C5 clones).